Our hypothesis is that infectious stimuli lead to a marker profile of neutrophils and monocytes that allows the distinction of patients with increased risk of infectious complications from those without, despite the general inflammatory state…
ID
Bron
Verkorte titel
Aandoening
Postoperative infectious complications that occur within 30 days after surgery.
- Colorectal Anastomotic Leakage (CAL)
- Intra-abdominal abscess
- Sepsis
- Urinary Tract Infection (UTI)
- Pneumonia
- Surgical Site Infection (SSI
Ondersteuning
P.O. Box 2040, 3000 CA Rotterdam, The Netherlands, internal postal address Rg-2
Visiting address: office EE-173, Dr.Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Email p.edomskis@erasmusmc.nl | Telephone +31 10 704 36 83
www.erasmusmc.nl
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Postoperative infectious complications that occur before and/or at presentation at first outpatient department visit, or within 30 days after surgery.<br><br>
- Colorectal Anastomotic Leakage (CAL)<br>
We defined CAL as an insufficiency of the anastomosis, demonstrated by either endoscopy, CT-scan and/or (water-soluble) contrast enema or re-operation(39).<br><br>
- Intra-abdominal abscess<br>
Intra-abdominal abscesses demonstrated by imaging studies or with the need to be verified by either surgical drainage or by ultrasonographically, or CT guided aspiration of pus.
<br><br>
- Sepsis<br>
Sepsis was defined by clinical symptoms, if possible combined with a positive blood culture.
<br><br>
- Urinary Tract Infection (UTI)<br>
UTI was defined by a positive urine culture and/or requirement of antibiotic treatment.
<br><br>
- Pneumonia<br>
Pneumonia was defined by a positive X-ray and/or requirement of antibiotic treatment.
<br><br>
- Surgical Site Infection (SSI) <br>
SSI is defined as the presence of pus, either discharged spontaneously or requiring drainage, at the surgical site.
Achtergrond van het onderzoek
Rationale: Our hypothesis is that infectious stimuli lead to a marker profile of neutrophils and monocytes that allows the distinction of patients with increased risk of infectious complications from those without, despite the general inflammatory state induced by the surgical procedure.
Objective: To assess the predictive value of immune monitoring after colorectal surgery for early detection of postoperative infectious complications.
Study design: The IMACS study is a prospective pilot study that assesses the predictive value of immune monitoring after colorectal surgery for early detection of infectious complications. The expression of CD markers of myelomoncytic populations in peripheral blood will be determined with FACS analysis. A blood samples of 10 mL is required before surgery and 3 mL daily at the first three days after surgery.
Study population: The source population for this pilot study will be patients who undergo colorectal resection for malignancies. Patients who undergo Hemicolectomy Left, Hemicolectomy Right, Sigmoid Resection or Partial Mesorectal Excision (PME) / Total Mesorectal Excision (TME) will be eligible for inclusion.
Intervention (if applicable): Not applicable
Main study parameters/endpoints:
Postoperative infectious complications that occur within 30 days after surgery.
- Colorectal Anastomotic Leakage (CAL)
- Intra-abdominal abscess
- Sepsis
- Urinary Tract Infection (UTI)
- Pneumonia
- Surgical Site Infection (SSI)
Doel van het onderzoek
Our hypothesis is that infectious stimuli lead to a marker profile of neutrophils and monocytes that allows the distinction of patients with increased risk of infectious complications from those without, despite the general inflammatory state induced by the surgical procedure.
Onderzoeksopzet
singel timepoint
Onderzoeksproduct en/of interventie
blood collection
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients who undergo Hemicolectomy Left, Hemicolectomy Right, Sigmoid Resection or Partial Mesorectal Excision (PME) / Total Mesorectal Excision (TME) will be eligible for inclusion.
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Informed Consent
- Primary anastomosis
- Colorectal carcinoma
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Age < 18 years
- Pregnancy
- Preoperative chemotherapy and/or radiotherapy
- Perioperative HIPEC treatment
- Inflammatory disease (i.e. inflammatory bowel disease, auto-immune deficiencies)
- Immunosuppressant drug use
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL7369 |
| NTR-old | NTR7577 |
| CCMO | NL59261.078.16 |
| OMON | NL-OMON49208 |